Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside-Reference-Cited by-同舟云学术

Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside

Published:2019-11 Issue: Volume:122 Page:22-41
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Abdel-Aziz Amal Kamal^ORCID,Saadeldin Mona Kamal^ORCID,D'Amico Paolo,Orecchioni Stefania,Bertolini Francesco,Curigliano Giuseppe^ORCID,Minucci Saverio

Funder

AIRC

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference87 articles.

1. Breast cancer;World Health Organization,2019

2. Translational research in breast cancer;Chu;Surg Oncol Clin N Am,2008

3. Current challenges of metastatic breast cancer;Lim;Cancer Metastasis Rev,2016

4. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors;Herschkowitz;Genome Biol,2007

5. Deconstructing the molecular portraits of breast cancer;Prat;Mol Oncol,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bibliometric analysis of drug resistance in immunotherapy for breast cancer: trends, themes, and research focus;Frontiers in Immunology;2024-08-12

2. Deciphering the Complex Interplay of Long Noncoding RNAs and Aurora Kinases: Novel Insights into Breast Cancer Development and Therapeutic Strategies;Future Pharmacology;2024-07-30

3. Advances in acute myeloid leukemia differentiation therapy: A critical review;Biochemical Pharmacology;2023-09

4. Targeting Breast Cancer: The Familiar, the Emerging, and the Uncharted Territories;Biomolecules;2023-08-25

5. Discovery of EMD37, a 1,2,4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity;Biochemical Pharmacology;2022-12